These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Feline model of acute nipah virus infection and protection with a soluble glycoprotein-based subunit vaccine. Mungall BA; Middleton D; Crameri G; Bingham J; Halpin K; Russell G; Green D; McEachern J; Pritchard LI; Eaton BT; Wang LF; Bossart KN; Broder CC J Virol; 2006 Dec; 80(24):12293-302. PubMed ID: 17005664 [TBL] [Abstract][Full Text] [Related]
29. Crystal structure of the Hendra virus attachment G glycoprotein bound to a potent cross-reactive neutralizing human monoclonal antibody. Xu K; Rockx B; Xie Y; DeBuysscher BL; Fusco DL; Zhu Z; Chan YP; Xu Y; Luu T; Cer RZ; Feldmann H; Mokashi V; Dimitrov DS; Bishop-Lilly KA; Broder CC; Nikolov DB PLoS Pathog; 2013; 9(10):e1003684. PubMed ID: 24130486 [TBL] [Abstract][Full Text] [Related]
30. Fc-Based Recombinant Henipavirus Vaccines Elicit Broad Neutralizing Antibody Responses in Mice. Li Y; Li R; Wang M; Liu Y; Yin Y; Zai X; Song X; Chen Y; Xu J; Chen W Viruses; 2020 Apr; 12(4):. PubMed ID: 32340278 [TBL] [Abstract][Full Text] [Related]
31. Acute Hendra virus infection: Analysis of the pathogenesis and passive antibody protection in the hamster model. Guillaume V; Wong KT; Looi RY; Georges-Courbot MC; Barrot L; Buckland R; Wild TF; Horvat B Virology; 2009 May; 387(2):459-65. PubMed ID: 19328514 [TBL] [Abstract][Full Text] [Related]
32. Newcastle disease virus-vectored Nipah encephalitis vaccines induce B and T cell responses in mice and long-lasting neutralizing antibodies in pigs. Kong D; Wen Z; Su H; Ge J; Chen W; Wang X; Wu C; Yang C; Chen H; Bu Z Virology; 2012 Oct; 432(2):327-35. PubMed ID: 22726244 [TBL] [Abstract][Full Text] [Related]
33. Vaccination of ferrets with a recombinant G glycoprotein subunit vaccine provides protection against Nipah virus disease for over 12 months. Pallister JA; Klein R; Arkinstall R; Haining J; Long F; White JR; Payne J; Feng YR; Wang LF; Broder CC; Middleton D Virol J; 2013 Jul; 10():237. PubMed ID: 23867060 [TBL] [Abstract][Full Text] [Related]
34. Construction of the safe neutralizing assay system using pseudotyped Nipah virus and G protein-specific monoclonal antibody. Bae SE; Kim SS; Moon ST; Cho YD; Lee H; Lee JY; Shin HY; Lee HJ; Kim YB Biochem Biophys Res Commun; 2019 Jun; 513(4):781-786. PubMed ID: 30995971 [TBL] [Abstract][Full Text] [Related]
35. Advances in diagnostics, vaccines and therapeutics for Nipah virus. Thakur N; Bailey D Microbes Infect; 2019; 21(7):278-286. PubMed ID: 30817995 [TBL] [Abstract][Full Text] [Related]
36. Nipah Virus C and W Proteins Contribute to Respiratory Disease in Ferrets. Satterfield BA; Cross RW; Fenton KA; Borisevich V; Agans KN; Deer DJ; Graber J; Basler CF; Geisbert TW; Mire CE J Virol; 2016 Jul; 90(14):6326-6343. PubMed ID: 27147733 [TBL] [Abstract][Full Text] [Related]
37. Resistance of Cynomolgus Monkeys to Nipah and Hendra Virus Disease Is Associated With Cell-Mediated and Humoral Immunity. Prasad AN; Woolsey C; Geisbert JB; Agans KN; Borisevich V; Deer DJ; Mire CE; Cross RW; Fenton KA; Broder CC; Geisbert TW J Infect Dis; 2020 May; 221(Suppl 4):S436-S447. PubMed ID: 32022850 [TBL] [Abstract][Full Text] [Related]
38. Type I interferon signaling protects mice from lethal henipavirus infection. Dhondt KP; Mathieu C; Chalons M; Reynaud JM; Vallve A; Raoul H; Horvat B J Infect Dis; 2013 Jan; 207(1):142-51. PubMed ID: 23089589 [TBL] [Abstract][Full Text] [Related]